Richard E. Kolinski

589 total citations
15 papers, 477 citations indexed

About

Richard E. Kolinski is a scholar working on Cell Biology, Molecular Biology and Surgery. According to data from OpenAlex, Richard E. Kolinski has authored 15 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cell Biology, 7 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Richard E. Kolinski's work include Proteoglycans and glycosaminoglycans research (8 papers), Glycosylation and Glycoproteins Research (6 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Richard E. Kolinski is often cited by papers focused on Proteoglycans and glycosaminoglycans research (8 papers), Glycosylation and Glycoproteins Research (6 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Richard E. Kolinski collaborates with scholars based in United States, Italy and Thailand. Richard E. Kolinski's co-authors include Lucinda F. Buhse, Benjamin J. Westenberger, David A. Keire, Michael L. Trehy, John C. Reepmeyer, Hongping Ye, Robert F. Steiner, Wei Ye, John Spencer and Anna M. Wokovich and has published in prestigious journals such as Biochemistry, Analytical Biochemistry and Molecules.

In The Last Decade

Richard E. Kolinski

15 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard E. Kolinski United States 11 192 189 95 71 60 15 477
Joëlle De Meutter Belgium 14 423 2.2× 22 0.1× 73 0.8× 86 1.2× 89 1.5× 17 667
Márkó Grabarics Germany 12 254 1.3× 66 0.3× 20 0.2× 12 0.2× 6 0.1× 17 428
Sara Tortorella Italy 14 288 1.5× 25 0.1× 17 0.2× 10 0.1× 7 0.1× 24 617
André Huss Eriksson Denmark 12 99 0.5× 11 0.1× 20 0.2× 14 0.2× 12 0.2× 17 487
Kamila Sofińska Poland 12 132 0.7× 15 0.1× 44 0.5× 85 1.2× 8 0.1× 31 388
Kiyoshi Iwamoto Japan 13 296 1.5× 18 0.1× 10 0.1× 6 0.1× 16 0.3× 25 482
Mustafa Grit Netherlands 9 479 2.5× 19 0.1× 12 0.1× 6 0.1× 18 0.3× 9 794
Mohan Boggara United States 9 362 1.9× 8 0.0× 48 0.5× 15 0.2× 16 0.3× 9 508
Ignace Hanssens Belgium 17 480 2.5× 34 0.2× 11 0.1× 8 0.1× 9 0.1× 32 697
N. Grubhofer Germany 10 178 0.9× 42 0.2× 22 0.2× 5 0.1× 13 0.2× 15 381

Countries citing papers authored by Richard E. Kolinski

Since Specialization
Citations

This map shows the geographic impact of Richard E. Kolinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Kolinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Kolinski more than expected).

Fields of papers citing papers by Richard E. Kolinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Kolinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Kolinski. The network helps show where Richard E. Kolinski may publish in the future.

Co-authorship network of co-authors of Richard E. Kolinski

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Kolinski. A scholar is included among the top collaborators of Richard E. Kolinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Kolinski. Richard E. Kolinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mazzini, Giulia, et al.. (2017). Combining NMR Spectroscopy and Chemometrics to Monitor Structural Features of Crude Hep-arin. Molecules. 22(7). 1146–1146. 22 indexed citations
2.
Mans, Daniel J., Hongping Ye, Jamie D. Dunn, et al.. (2015). Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin. Analytical Biochemistry. 490. 52–54. 8 indexed citations
3.
Ye, Hongping, Timothy K. Toby, Cynthia D. Sommers, et al.. (2013). Characterization of currently marketed heparin products: Key tests for LMWH quality assurance. Journal of Pharmaceutical and Biomedical Analysis. 85. 99–107. 28 indexed citations
4.
Sommers, Cynthia D., Hongping Ye, Richard E. Kolinski, et al.. (2011). Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns. Analytical and Bioanalytical Chemistry. 401(8). 2445–2454. 32 indexed citations
5.
Keire, David A., Daniel J. Mans, Hongping Ye, Richard E. Kolinski, & Lucinda F. Buhse. (2010). Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches. Journal of Pharmaceutical and Biomedical Analysis. 52(5). 656–664. 35 indexed citations
6.
Keire, David A., Hongping Ye, Michael L. Trehy, et al.. (2010). Characterization of currently marketed heparin products: key tests for quality assurance. Analytical and Bioanalytical Chemistry. 399(2). 581–591. 32 indexed citations
7.
Keire, David A., Michael L. Trehy, John C. Reepmeyer, et al.. (2009). Analysis of crude heparin by 1H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate. Journal of Pharmaceutical and Biomedical Analysis. 51(4). 921–926. 54 indexed citations
8.
Trehy, Michael L., John C. Reepmeyer, Richard E. Kolinski, Benjamin J. Westenberger, & Lucinda F. Buhse. (2008). Analysis of heparin sodium by SAX/HPLC for contaminants and impurities. Journal of Pharmaceutical and Biomedical Analysis. 49(3). 670–673. 70 indexed citations
9.
Buhse, Lucinda F., Richard E. Kolinski, Benjamin J. Westenberger, et al.. (2005). Topical drug classification. International Journal of Pharmaceutics. 295(1-2). 101–112. 72 indexed citations
10.
Westenberger, Benjamin J., Christopher D. Ellison, Richard E. Kolinski, et al.. (2005). Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques. International Journal of Pharmaceutics. 306(1-2). 56–70. 69 indexed citations
11.
Kolinski, Richard E., et al.. (1986). Stability of reserpine injections and tablets submitted by U.S. hospitals. American Journal of Health-System Pharmacy. 43(1). 103–109. 1 indexed citations
12.
Kolinski, Richard E., et al.. (1983). Stability of Sterile Dexamethasone Acetate Suspensions and Dexamethasone Sodium Phosphate Injections Submitted by U.S. Hospitals. American Journal of Health-System Pharmacy. 40(12). 2165–2169. 3 indexed citations
13.
Gurka, Donald F., et al.. (1980). Scope of Differential UV and Differential Fluorescence Assays for Phenothiazines: Comparison with Official Methods. Journal of Pharmaceutical Sciences. 69(9). 1069–1074. 22 indexed citations
14.
Steiner, Robert F., Ira Weinryb, & Richard E. Kolinski. (1970). The low temperature luminescence of complexes of acridine orange with polyelectrolytes. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 209(2). 306–319. 4 indexed citations
15.
Steiner, Robert F. & Richard E. Kolinski. (1968). Phosphorescence of oligopeptides containing tryptophan and tyrosine. Biochemistry. 7(3). 1014–1018. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026